The Company Continues to Expand Its Presence in Sub-Saharan Africa
BIOTESTLAB Earns ISO 14001:2015 Certification
BIOTESTLAB Receives International Environmental Certification ISO 14001:2015
26/02/2026
BIOTESTLAB supported the 2nd All-Ukrainian Veterinary Ophthalmological Symposium
The company acted as an official partner of the key industry event of this year
23/02/2026
BIOTESTLAB strengthens LATAM presence following 2026 IPPE debut
BIOTESTLAB took part in the International Production & Processing Expo (2026 IPPE) in Atlanta, USA
01/02/2026
BIOTESTLAB expands its portfolio for companion animals with TOBRANORM
A new tobramycin 0.3%–based solution for the treatment of bacterial eye diseases in dogs and cats
22/01/2026